Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.0%

2 terminated out of 40 trials

Success Rate

92.6%

+6.1% vs benchmark

Late-Stage Pipeline

25%

10 trials in Phase 3/4

Results Transparency

12%

3 of 25 completed with results

Key Signals

3 with results93% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (14)
P 1 (4)
P 2 (8)
P 3 (4)
P 4 (6)

Trial Status

Completed25
Unknown6
Terminated2
Suspended2
Not Yet Recruiting2
Recruiting2

Trial Success Rate

92.6%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (40)

Showing 20 of 20 trials
NCT07487220Not ApplicableCompletedPrimary

Non-invasive Remote Ischemic PreConditioning (RIPC) in Free Flaps for Breast Reconstruction

NCT07263347Not Yet Recruiting

DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes

NCT06097702Phase 1CompletedPrimary

A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants

NCT06582485Phase 2Not Yet RecruitingPrimary

A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD Kidneys

NCT00224406Phase 2CompletedPrimary

Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation

NCT06552442Phase 2CompletedPrimary

Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Glucocorticoid Treatment for No-Reflow in STEMI

NCT06141525Not ApplicableRecruiting

Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting

NCT05246618Phase 1CompletedPrimary

FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation

NCT05585255Recruiting

Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury

NCT05598177Phase 4CompletedPrimary

Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass

NCT05215743Phase 1Completed

Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.

NCT00248040Phase 2CompletedPrimary

Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation

NCT05327348Phase 3Unknown

Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery

NCT00948194Not ApplicableTerminated

Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation

NCT04307290Phase 4Completed

Dexmedetomidine on Tourniquet Induced -Systemic Effects

NCT04284592Not ApplicableCompletedPrimary

Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery

NCT01739088Not ApplicableCompleted

Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery

NCT03818126Not ApplicableCompleted

The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement

NCT03318575Not ApplicableUnknownPrimary

Remote Ischemic Conditioning Using the autoRIC

NCT02833688Phase 4CompletedPrimary

Effects of Dexmedetomidine on the Liver Injury After Hepatectomy

Scroll to load more

Research Network

Activity Timeline